National Health Investors, Inc. $NHI Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lowered its holdings in National Health Investors, Inc. (NYSE:NHI) by 0.7% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,426 shares of the real estate investment trust’s stock after selling 146 shares during the period. Janney Montgomery Scott LLC’s holdings in National Health Investors were worth $1,432,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC grew its holdings in shares of National Health Investors by 15.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust’s stock valued at $268,000 after purchasing an additional 495 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in National Health Investors by 5.6% during the 1st quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust’s stock worth $43,494,000 after acquiring an additional 31,451 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of National Health Investors by 11.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust’s stock valued at $267,000 after purchasing an additional 357 shares during the last quarter. SG Americas Securities LLC purchased a new stake in shares of National Health Investors in the 1st quarter valued at approximately $808,000. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of National Health Investors by 3.3% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust’s stock valued at $35,372,000 after purchasing an additional 15,497 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on NHI. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday, October 8th. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They set an “overweight” rating and a $90.00 target price for the company. KeyCorp upgraded shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Wedbush upgraded shares of National Health Investors to a “strong-buy” rating in a research note on Wednesday, July 2nd. Finally, Truist Financial boosted their target price on shares of National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $84.83.

National Health Investors Stock Down 0.1%

Shares of NYSE:NHI opened at $73.75 on Monday. The stock has a market cap of $3.50 billion, a P/E ratio of 23.56, a P/E/G ratio of 3.36 and a beta of 0.77. The firm has a fifty day moving average price of $77.07 and a 200 day moving average price of $74.12. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. National Health Investors, Inc. has a 1-year low of $65.13 and a 1-year high of $82.32.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.18 EPS. Sell-side analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date is Tuesday, September 30th. This is an increase from National Health Investors’s previous quarterly dividend of $0.90. National Health Investors’s payout ratio is currently 117.57%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.